 |
|
|
44th Annual Meeting
American Society of Clinical Oncology
May 30 - June 3, 2008 | Chicago, Illinois
|
 |
|
Highlights from ASCO 2008
The results from thousands of cancer research studies were presented at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Ill., from May 30 - June 3, 2008. Nearly 25,000 cancer specialists from around the world gathered to discuss the latest advances in cancer care, treatment, and prevention.
|
|
Colorectal Cancer Drugs Require Careful Patient Selection
(Posted: 06/18/2008) - Patients with advanced colorectal cancer who have mutant forms of the gene KRAS in their tumors should not receive chemotherapy plus cetuximab (Erbitux), because they are unlikely to benefit from the treatment, according to findings presented at the 2008 ASCO meeting in Chicago.
Zoledronic Acid Improves Early Breast Cancer Treatment
(Posted: 06/19/2008, Reviewed: 09/16/2008) - The addition of zoledronic acid (Zometa) to adjuvant endocrine therapy in premenopausal women with early stage breast cancer significantly improves clinical outcomes beyond those achieved with endocrine therapy alone, according to findings presented at the 2008 ASCO meeting in Chicago.
Cetuximab Plus Chemotherapy Extends Survival for Advanced Lung Cancer
(Posted: 06/19/2008) - Patients with advanced non-small-cell lung cancer who received cetuximab (Erbitux) plus chemotherapy lived on average five weeks longer than patients who received chemotherapy alone, according to findings presented at the 2008 ASCO meeting in Chicago.
Carboplatin May Be Less Toxic Than Radiation for Seminoma
(Posted: 06/07/2004, Updated: 06/23/2008) - One shot of carboplatin may be as effective as radiation therapy in treating early seminoma, a kind of testicular cancer, according to updated findings presented at the 2008 ASCO meeting in Chicago.
Gemcitabine after Pancreatic Cancer Surgery Improves Survival
(Posted: 06/24/2008) - Patients who received the chemotherapy drug gemcitabine after surgery for pancreatic cancer lived two months longer than patients who had surgery alone, according to findings presented at the 2008 ASCO meeting in Chicago.
|
|
|
